Definium Therapeutics Inc. Common Shares vs Ondas Inc. Common Stock — how do they compare? Definium Therapeutics Inc. Common Shares trades at $35.4 (market cap $4.59B), while Ondas Inc. Common Stock trades at $6.91 (market cap $3.99B). The key difference: Definium Therapeutics Inc. Common Shares is the larger of the two by market cap, and Definium Therapeutics Inc. Common Shares is trading nearer its 52-week high, Ondas Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Ondas Inc. Common Stock for 0 Days on average.
| DFTX | ONDS | |
|---|---|---|
Market Cap | $4.59B | $3.99B |
Volume | 2,103,937 | 60,542,247 |
Sector | Health | Technology |
52-Week High | $48.45 | $14.01 |
52-Week Low | $10.68 | $5.25 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.55B | $2.62B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →Ondas provides autonomous systems and private wireless solutions through its Ondas Autonomous Systems, Ondas Capital, and Ondas Networks business units. Its technologies combine aerial intelligence and next-generation connectivity for essential industries.
Read more on ONDS →